Cargando…
Now is it time to implement spacers in cervical cancer brachytherapy?
Although the international study on MRI-guided brachytherapy in cervical cancer (EMBRACE-I) demonstrated excellent local control regardless of the T stage, up to 14.6% of grade 3–5 late radiation-related toxicities were observed, which is unacceptable. While the efficacy of hydrogel spacers has been...
Autores principales: | Murakami, Naoya, Okuma, Kae, Kato, Tomoyasu, Igaki, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303596/ https://www.ncbi.nlm.nih.gov/pubmed/35726343 http://dx.doi.org/10.1093/jrr/rrac031 |
Ejemplares similares
-
Technical Note: High-Dose-Rate Interstitial Brachytherapy for Pelvic Sidewall Recurrence Using Intraperitoneal Spacers
por: Miyata, Yusaku, et al.
Publicado: (2022) -
Transvaginal artificial ascites infusion as a spacer in gynecological brachytherapy: a novel technique
por: Karube, Masataka, et al.
Publicado: (2020) -
Combined Interstitial and Intracavitary High-Dose Rate Brachytherapy of Cervical Cancer
por: Itami, Jun, et al.
Publicado: (2022) -
How should we appropriately classify low-risk uterine cervical cancer patients suitable for de-intensified treatment?
por: Murakami, Naoya, et al.
Publicado: (2022) -
Effect of Hyaluronate Acid Injection on Dose-Volume Parameters in Brachytherapy for Cervical Cancer
por: Kobayashi, Rei, et al.
Publicado: (2022)